Concepedia
Statistics
Publications
13
Citations
1.2K
H-Index
Active since
1992
Affiliations
Karolinska Institutet(Current)
Karolinska University Hospital
Universidad de Extremadura
Integrated Cardio Metabolic Centre
Uppsala University Hospital
Marja-Liisa Dahl is an author at Karolinska Institutet specializing in pharmacology, pharmacogenetics, and pharmacokinetics.
Publications per year
1992–2003
Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish Population
Ümit Yaşar, Erik Eliasson, Marja-Liisa Dahl et al. · Biochemical and Biophysical Research Communications · 1999 · 252 citations
Life Sciences, Genetics, Molecular Genetics +7
Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype
Ming Chang, Marja-Liisa Dahl, Gunnel Tybring et al. · Pharmacogenetics · 1995 · 203 citations
Medicine, Pharmacokinetics, Pharmacology +13
CYP2C19 genotype and phenotype determined by omeprazole in a Korean population
Hyung‐Keun Roh, Marja-Liisa Dahl, Gunnel Tybring et al. · Pharmacogenetics · 1996 · 119 citations
Veterinary Medicine, Pharmacokinetics, Pharmacology +16
The CYP2D6 genotype predicts the oral clearance of the neuroleptic agents perphenazine and zuclopenthixol*
Markus Jerling, Marja-Liisa Dahl, Anna Åberg-Wistedt et al. · Clinical Pharmacology & Therapeutics · 1996 · 101 citations
Pharmacy, Pharmacokinetics, Pharmacology +16
CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers
Pedro Dorado, Roland Berecz, Maria-Jes�s Norberto et al. · European Journal of Clinical Pharmacology · 2003 · 100 citations
Medicine, Pharmacokinetics, Pharmacology +12
1–5 of 13